Search - tctmd.com

Displaying 921 - 940 of 976

Sort: Relevancy | Date

News Daily News

Finding CAD on Elective Angiography Varies Widely Among Hospitals

August 08, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

July 25, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

News Daily News

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Jason Kahn

June 20, 2011

News Daily News

Study Finds All-Comers Design Not So All Inclusive

Caitlin E. Cox

June 15, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

News Daily News

Novel Stent Appears to Outperform Medical Therapy for Intracranial Stenosis

June 08, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Canada Approves Ticagrelor in ACS Patients

June 02, 2011

News Daily News

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Caitlin E. Cox

May 27, 2011

Advertisement

Finding CAD on Elective Angiography Varies Widely Among Hospitals

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Delayed Primary PCI Generally Superior to Early Fibrinolysis for STEMI

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Study Finds All-Comers Design Not So All Inclusive

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Novel Stent Appears to Outperform Medical Therapy for Intracranial Stenosis

Syntax Score Predicts 1-Year Risk in ACS Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Canada Approves Ticagrelor in ACS Patients

Meta-analysis Demonstrates Mixed Evidence on CABG in ACS Patients Taking Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content